Daniel Ek: Life After Spotify, Broken Healthcare Incentives, Catching Disease Early & AI's Potential
Can Spotify’s playbook help move healthcare from reactive treatment to prevention? Daniel Ek joins Jason and Friedberg to unpack Spotify’s climb to over 700 million active users, the licensing bets behind subscription music and his shift to Neko. They discuss longitudinal data, AI, wearables, clinician-led diagnostics and funding preventive care in the U.S.
Key Points
- Daniel Ek described how Spotify was built through years of licensing negotiations, market-by-market expansion, and a willingness to bet on subscription music before it was obvious.
- He argued that healthcare needs to move from reactive treatment to prevention by collecting far richer longitudinal data, which is the core idea behind Neko’s diagnostic model.
- He emphasized that AI and wearables become most powerful when paired with clinicians and repeated measurements over time, turning early detection into real behavior change and better outcomes.
Chapters
| 0:00 | |
| 1:40 | |
| 2:00 | |
| 5:44 | |
| 6:17 | |
| 10:20 | |
| 13:38 | |
| 15:13 | |
| 19:17 | |
| 27:22 | |
| 31:45 | |
| 36:03 | |
| 44:24 | |
| 47:28 | |
| 49:47 |
Transcript
Loading transcript...
- / -





